Sponsor:
Janssen Research & Development, LLC
Code:
NCT05250973
Conditions
Amyloidosis
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Daratumumab
Cyclophosphamide
Bortezomib
Dexamethasone
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations